SAN DIEGO, May 11, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced James Levine, President and Chief Executive Officer, will present at two upcoming conferences.
Mr. Levine will present at the upcoming Barclays Capital Clean Solutions Conference as part of the "Biofuels" panel discussion scheduled from 1:30 – 3:00 p.m. ET on Thursday, May 19, 2011 in New York City. Webcast information is unavailable at this time and will be posted to the "Investors" section of the Verenium website when available.
Mr. Levine will also present at the upcoming at the Stifel Nicolaus 2011 Cleantech Conference on Tuesday, May 24, 2011. The presentation is expected to begin at 10:15 a.m. ET and will take place at the Omni Berkshire Place in New York City. The live webcast may be accessed by visiting the "Investors" section of Verenium's website at www.verenium.com. A webcast replay will be accessible for 30 days following the conference.
About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes. Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets. Read more at www.verenium.com.
Forward-Looking StatementsStatements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnersh
|SOURCE Verenium Corporation|
Copyright©2010 PR Newswire.
All rights reserved